Literature DB >> 15478068

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.

M Louise Herlocher1, Rachel Truscon, Stephanie Elias, Hui-Ling Yen, Noel A Roberts, Suzanne E Ohmit, Arnold S Monto.   

Abstract

Three type A influenza viruses, each of which has a distinct neuraminidase-gene mutation and is resistant to the neuraminidase inhibitor oseltamivir, have been isolated. Previously, in the ferret model, an R292K mutant of a type A (H3N2) virus was not transmitted under conditions in which the wild-type virus was transmitted. This model was used to investigate whether the E119V mutant of a type A (H3N2) virus and the H274Y mutant of a type A (H1N1) virus would be transmitted under similar circumstances. Both mutant viruses were transmitted, although the H274Y mutant required a 100-fold-higher dose for infection of donor ferrets and was transmitted more slowly than was the wild type. Both the mutant and the wild-type viruses retained their genotypic characteristics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15478068     DOI: 10.1086/424572

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  132 in total

1.  The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.

Authors:  Wai Lan Wu; Siu-Ying Lau; Yixin Chen; Genyan Wang; Bobo Wing-Yee Mok; Xi Wen; Pui Wang; Wenjun Song; Tianwei Lin; Kwok-Hung Chan; Kwok-Yung Yuen; Honglin Chen
Journal:  Antiviral Res       Date:  2011-11-25       Impact factor: 5.970

2.  Emerging influenza antiviral resistance threats.

Authors:  Frederick G Hayden; Menno D de Jong
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

3.  Evolution, safety, and highly pathogenic influenza viruses.

Authors:  Marc Lipsitch; Joshua B Plotkin; Lone Simonsen; Barry Bloom
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

4.  The effects of a deleterious mutation load on patterns of influenza A/H3N2's antigenic evolution in humans.

Authors:  Katia Koelle; David A Rasmussen
Journal:  Elife       Date:  2015-09-15       Impact factor: 8.140

5.  Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir.

Authors:  M A Rameix-Welti; F Agou; P Buchy; S Mardy; J T Aubin; M Véron; S van der Werf; N Naffakh
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

6.  Analysis of oseltamivir resistance substitutions in influenza virus glycoprotein neuraminidase using a lentivirus-based surrogate assay system.

Authors:  Jennifer Tisoncik-Go; Katie S Cordero; Lijun Rong
Journal:  Virol Sin       Date:  2013-02-06       Impact factor: 4.327

7.  How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example.

Authors:  Andreas Handel; Victoria Akin; Sergei S Pilyugin; Veronika Zarnitsyna; Rustom Antia
Journal:  J R Soc Interface       Date:  2014-01-15       Impact factor: 4.118

8.  Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.

Authors:  Andreas Handel; Ira M Longini; Rustom Antia
Journal:  J Theor Biol       Date:  2008-10-08       Impact factor: 2.691

9.  Bifunctional polymeric inhibitors of human influenza A viruses.

Authors:  Jayanta Haldar; Luis Alvarez de Cienfuegos; Terrence M Tumpey; Larisa V Gubareva; Jianzhu Chen; Alexander M Klibanov
Journal:  Pharm Res       Date:  2009-12-15       Impact factor: 4.200

10.  Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks.

Authors:  Jenna E Achenbach; Richard A Bowen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.